The EU and Russia agree on mutual recognition of clinical trials
Health ministry of the Russian Federation has reached an agreement with the European Union (EU) on the issue of mutual recognition of clinical research, said the head of department Golikova.
© Chameleon Pharma Consulting(firmenpresse) - "We have to soon sign a document that would address issues concerned the mutual recognition of clinical trials,"
said the Minister after his meeting with EU Commissioner of Health John Dalli.
The goal is:
•To regulate standards and practices of clinical research
•If products have already passed in the EU, they should not be conducted again in Russia.
The Minister and the EU Commissioner also discussed the issues of food security and illegal production of drugs.
Golikov recalled that on the 28th of October in Moscow the agreement will be signed by the convention MEDICRIME, which will be the first international legal instrument to provide criminal liability for the manufacture and supply of counterfeit medical products and similar crimes. The meeting also raised issues of infectious diseases and tobacco control. "The results of the meeting, I think, are very positive, I must say that the EU considers Russia as an essential partner, "- said the minister John Dalli.
Chameleon Pharma Consulting comments: This is a good step for even faster registration in Russia. Regulatory experts will have a common basis of reference.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Chameleon Pharma Consulting is an expert for Sales & Marketing, M & A, Distribution, Regulatory, R & D in the CIS region (Russia, Ukraine, Kazakhstan, Uzbekistan, Belarus etc.) and Eastern Europe (Poland, Rumania, Bulgaria etc.) and has a wide network with longstanding contacts. Chameleon Pharma Consulting is based close to the former airport Berlin Tempelhof in the heart of the German capital.
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
Tel: 030 / 64 83 20 06
Fax: 030 / 64 83 20 08
Internet: www.chameleon-pharma.com
E-mail: service(at)chameleon-pharma.com
Presse contact:
Chameleon Pharma Consulting
Ms. Irina Prokopets
Am Tempelhofer Berg 6
10965 Berlin, Germany
Phone: 030 64825167
Fax: 030 64832008
E-mail: irpr(at)chameleon-pharma.com
Datum: 09.11.2011 - 14:43 Uhr
Sprache: Deutsch
News-ID 516611
Anzahl Zeichen: 1420
Kontakt-Informationen:
Kategorie:
Wirtschaft (allg.)
Meldungsart: Finanzinformation
Versandart: Veröffentlichung
Freigabedatum: 07.11.2011
Diese Pressemitteilung wurde bisher 256 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"The EU and Russia agree on mutual recognition of clinical trials "
steht unter der journalistisch-redaktionellen Verantwortung von
Chameleon Pharma Consulting (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
